CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives.

Abstract : Despite increasing efforts and support for anti-malarial drug R&D, globally anti-malarial drug discovery and development remains largely uncoordinated and fragmented. The current window of opportunity for large scale funding of R&D into malaria is likely to narrow in the coming decade due to a contraction in available resources caused by the current economic difficulties and new priorities (e.g. climate change). It is, therefore, essential that stakeholders are given well-articulated action plans and priorities to guide judgments on where resources can be best targeted.The CRIMALDDI Consortium (a European Union funded initiative) has been set up to develop, through a process of stakeholder and expert consultations, such priorities and recommendations to address them. It is hoped that the recommendations will help to guide the priorities of the European anti-malarial research as well as the wider global discovery agenda in the coming decade.
Type de document :
Article dans une revue
Malaria Journal, BioMed Central, 2010, 9 (1), pp.202. 〈10.1186/1475-2875-9-202〉
Liste complète des métadonnées

Littérature citée [7 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00617230
Contributeur : Ed. Bmc <>
Soumis le : vendredi 26 août 2011 - 15:39:41
Dernière modification le : jeudi 11 janvier 2018 - 06:21:10
Document(s) archivé(s) le : dimanche 27 novembre 2011 - 02:25:36

Fichiers

Identifiants

Collections

Citation

Ian Boulton, Solomon Nwaka, Ian Bathurst, Michael Lanzer, Donatella Taramelli, et al.. CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives.. Malaria Journal, BioMed Central, 2010, 9 (1), pp.202. 〈10.1186/1475-2875-9-202〉. 〈inserm-00617230〉

Partager

Métriques

Consultations de la notice

125

Téléchargements de fichiers

202